Literature DB >> 3949251

Sticking of dosage forms in the gastrointestinal tract.

C G Wilson, J G Hardy, S S Davis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3949251      PMCID: PMC1433216          DOI: 10.1136/gut.27.2.226

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  8 in total

1.  Gastrointestinal transit of an osmotic tablet drug delivery system.

Authors:  C G Wilson; J G Hardy
Journal:  J Pharm Pharmacol       Date:  1985-08       Impact factor: 3.765

2.  Where do all the tablets go?

Authors:  K T Evans; G M Roberts
Journal:  Lancet       Date:  1976-12-04       Impact factor: 79.321

3.  Intestinal perforation associated with osmotic slow release indomethacin capsules.

Authors:  T K Day
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-03

4.  Effect of posture and drink volume on the swallowing of capsules.

Authors:  K S Channer; J Virjee
Journal:  Br Med J (Clin Res Ed)       Date:  1982-12-11

5.  Esophageal retention of capsules.

Authors:  J A Ponto
Journal:  Am J Hosp Pharm       Date:  1983-01

6.  Effect of bolus composition on esophageal transit: concise communication.

Authors:  R S Fisher; L S Malmud; G Applegate; E Rock; S H Lorber
Journal:  J Nucl Med       Date:  1982-10       Impact factor: 10.057

7.  Development of a method for study of the tendency of drug products to adhere to the esophagus.

Authors:  M Marvola; K Vahervuo; A Sothmann; E Marttila; M Rajaniemi
Journal:  J Pharm Sci       Date:  1982-09       Impact factor: 3.534

8.  Pill-induced esophageal injury. Case reports and review of the medical literature.

Authors:  J W Kikendall; A C Friedman; M A Oyewole; D Fleischer; L F Johnson
Journal:  Dig Dis Sci       Date:  1983-02       Impact factor: 3.199

  8 in total
  1 in total

1.  Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS: a retrospective study.

Authors:  Dorsey M Bass; Mary Prevo; Deborah S Waxman
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.